COMMUNIQUÉS West-GlobeNewswire

-
Supernus Announces FDA Approval of sNDA to Expand Oxtellar XR® Label to Include Monotherapy
14/12/2018 - 22:02 -
UPDATE - Retrotope Announces First Dosing of RT001 in patients with Infantile Neuroaxonal Dystrophy (INAD)
14/12/2018 - 21:50 -
Apricus Biosciences Adjourns Special Meeting of Stockholders to New Date
14/12/2018 - 18:30 -
NOTICE OF EXTRAORDINARY GENERAL MEETING IN OASMIA PHARMACEUTICAL AB (PUBL)
14/12/2018 - 17:40 -
Sienna Announces December Dividend
14/12/2018 - 17:31 -
Diamond CBD, POTN Subsidiary Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules
14/12/2018 - 15:54 -
GOLDLINE CBD Brand 40% Off Site-Wide in Celebration of the 2018 Farm Bill
14/12/2018 - 15:00 -
Axovant Sciences Announces Pricing of $30 Million Public Offering of Common Shares
14/12/2018 - 15:00 -
ALK upgrades its full-year financial outlook due to accelerated sales
14/12/2018 - 14:33 -
IBEX Reports Results for the First Quarter Ended October 31, 2018
14/12/2018 - 14:00 -
Director/PDMR Shareholding
14/12/2018 - 14:00 -
Profound Medical Announces Changes to Commercial Organization
14/12/2018 - 14:00 -
Sport Endurance Engages INFOR Financial as Financial Advisor
14/12/2018 - 14:00 -
WishBone Medical, Inc. signs licensing agreement for the Guided Growth Plate
14/12/2018 - 14:00 -
Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
14/12/2018 - 13:30 -
Radient Technologies Inc. Ready to Serve $22B U.S. Market for Hemp-Derived CBD
14/12/2018 - 13:30 -
Bellicum Reports Safety Results and Promising Activity of Its Controlled CAR-T Candidate BPX-601 in Patients with Advanced Pancreatic Cancer at ESMO-IO
14/12/2018 - 13:00 -
Idera Pharmaceuticals Presents Clinical Safety and Efficacy Update from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment
14/12/2018 - 13:00 -
iKang Enters into Amendment No. 3 to Merger Agreement for Going Private Transaction
14/12/2018 - 12:15
Pages